Year: 2020

NASHUA, N.H., Nov. 25, 2020 (GLOBE NEWSWIRE) —  iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that researchers from Miguel Servet University Hospital in Zaragoza, Spain, will present new data from three clinical studies supporting the efficacy of the expanded Xoft® Axxent® Electronic Brachytherapy (eBx®) System® for the treatment of early-stage breast and endometrial cancers during the European Society for Radiotherapy & Oncology (ESTRO) 2020 meeting held virtually November 28 through December 1.The Company will highlight the latest technology for the expanded Xoft platform, including its full suite of applicators for existing and emerging applications in the virtual Xoft booth.“We’re thrilled to have new clinical evidence presented...

MONTREAL, Nov. 25, 2020 (GLOBE NEWSWIRE) — Xebec Adsorption Inc. (TSXV: XBC) (“Xebec”), a global provider of clean energy solutions, announced today that it has granted restricted stock units (“RSUs”) under the Corporation’s Stock Incentive Compensation Plan.A total of 9,000 RSUs were granted to an officer of the company upon hiring on October 5th, 2020 as per their Employment Contract with Xebec. The RSUs are payable in common shares of Xebec and will be vested in three equal installments of 3,000 over three years, after the date of the grant.Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.For more information:Xebec Adsorption Inc.Brandon Chow, Investor Relations Managerbchow@xebecinc.com+1...

MONTRÉAL, 25 nov. 2020 (GLOBE NEWSWIRE) — Xebec Adsorption Inc. (TSXV : XBC) (« Xebec »), fournisseur mondial de solutions d’énergie propre, est ravi d’annoncer aujourd’hui l’octroi d’unités d’actions restreintes (« UAR ») dans le cadre du Régime d’intéressement à base d’actions de l’entreprise.Le 5 octobre 2020, un total de 9 000 UAR a été octroyé à un dirigeant de l’entreprise dans le cadre de son embauche, conformément à son contrat de travail avec Xebec. Les UAR sont payables en actions ordinaires de Xebec et seront acquises en versements égaux de 3 000 actions au cours de trois ans, suivant la date de l’octroi. La Bourse de croissance TSX et son fournisseur de services de réglementation (tel que défini dans les politiques de la Bourse de croissance TSX) déclinent toute responsabilité quant à la pertinence ou à l’exactitude...

Parsippany, NJ, Nov. 25, 2020 (GLOBE NEWSWIRE) — Interpace Biosciences, Inc. (NASDAQ: IDXG) today announced that Jack Stover, President & Chief Executive Officer, will retire effective December 31, 2020. He will be replaced as President and Chief Executive Officer by Thomas Burnell, PhD., effective December 1, 2020. Mr. Stover, who will step down from the Interpace Board of Directors once Dr. Burnell joins the company and is appointed to the Board, will serve as an advisor to the company through the middle of 2021 in order to support the transition.Dr. Burnell joins Interpace with significant leadership experience with numerous healthcare companies, including a number of specialty clinical laboratories. This includes serving as President & CEO of Boston Heart Diagnostics, Viracor-IBT Laboratories and Eurofins Scientific,...

Sjá meðfylgjandi flöggunartilkynningu. ViðhengiLSR flöggun 25.11.20

WALL, N.J., Nov. 25, 2020 (GLOBE NEWSWIRE) — BIO-key International, Inc. (Nasdaq: BKYI), an innovative provider of identity and access management (IAM) solutions powered by biometrics, today announced that its Chairman & CEO Michael DePasquale will present at the 17th Annual Imperial Capital Security Investor Conference on Wednesday, December 2, 2020 at 12:30 pm ET. The Conference will connect approximately 70 public and private security-focused companies with 500 key investors and business leaders. For health and safety reasons, this year’s conference will take place virtually over two days December 2-3, 2020.Now in its 17th year, Imperial Capital’s Security Investor Conference remains the security industry’s leading investor conference, bringing together a select group of companies to present their positioning and strategic...

Long-term collaboration underpins BioNTech’s strategy to leverage Artificial Intelligence (AI) and Machine Learning (ML) technologies to support the discovery and development of novel immunotherapies based on InstaDeep’s DeepChainTM technology platformBioNTech and InstaDeep to establish a joint AI Innovation Lab to advance a portfolio of enterprise-wide digital initiatives in the areas of drug discovery and design, protein engineering, and operationsMAINZ, Germany and LONDON, United Kingdom, November 25, 2020 (GLOBE NEWSWIRE) — BioNTech SE (Nasdaq: BNTX, “BioNTech”) and InstaDeep Ltd today announced a multi-year strategic collaboration aimed at applying the latest advances in artificial intelligence (AI) and machine learning (ML) technology to develop novel immunotherapies for a range of cancers and infectious diseases.As part of...

Langfristige Kollaboration mit InstaDeep auf Basis ihrer DeepChainTM-Plattformtechnologie unterstützt BioNTechs Strategie, Artificial Intelligence (AI) und maschinelles Lernen für die Identifizierung und Entwicklung neuer Immuntherapien zu nutzen.BioNTech und InstaDeep bauen ein gemeinsames AI Innovation Lab auf, um eine Reihe unternehmensweiter digitaler Initiativen in den Bereichen Arzneimittelforschung und -design, Protein-Engineering und Betriebsabläufe voranzutreiben       MAINZ, Deutschland und LONDON, Vereinigtes Königreich, 25. November 2020 (GLOBE NEWSWIRE) — BioNTech SE (Nasdaq: BNTX, „BioNTech“) und InstaDeep Ltd gaben heute den Abschluss einer mehrjährigen strategischen Kollaboration bekannt, welche die neuesten Entwicklungen im Bereich Artificial Intelligence (AI) und maschinellem Lernen anwenden wird, um neue Immuntherapien...

TORONTO, Nov. 25, 2020 (GLOBE NEWSWIRE) — Goliath Resources Limited (TSX-V: GOT) (FSE: B4IF) (OTCQB: GOTRF) (the “Company” or “Goliath”) is pleased to report the receipt of all outstanding assay results for the 2020 field program on the Surebet discovery zone on its 100% controlled Golddigger property. It is located in the prolific Golden Triangle, B.C. near Auryn’s Homestake Ridge high-grade gold-silver resource and only 7km from the Dolly Varden mine access road.All outstanding channel samples assays have now been received across the Main Waterfall Zone and Upper Main Waterfall Zone. These new results have increased the average true width and grade. The high-grade polymetallic gold-silver hosting shear zone is now 9.84 meters at 10.68 gpt AuEq. It has 1000 meters of strike at surface and 500 meters of vertical relief with 1000...

The Company’s E-Commerce Platform No Longer has Any Individual Transaction ($) Dollar Limit ImposedNEW YORK, NY, Nov. 25, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with a proprietary line of functional “supplement” chewing gums (Flavors: Pomegranate, Blood Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant) as well as two ongoing Biotechnology initiatives, today announced the official transition of its E-Commerce payment processing to Square Inc. (“Square”).  From now on, the Company’s E-Commerce platform no longer has type of individual transaction ($) limit imposed (previously it had been set at $3,000).  The Company is also pleased to disclose that its E-Commerce website (www.taurigum.com) is...